AOD 9604 cost and availability
How much does AOD 9604 cost, where can you actually get it legally, and what changed after the FDA removed it from the compounding bulks list? Here's the honest regulatory and pricing picture.
- AOD 9604 is not FDA-approved and has no legitimate U.S. prescription pathway as of 2026.
- Before 2023, AOD 9604 was compounded under section 503A but was removed from the FDA bulks list in subsequent rulings.
- Historical compounding pharmacy prices ranged $80–$250/month for subcutaneous protocols.
- Research peptide market prices for 5 mg and 10 mg vials have ranged $30–$120 per vial, but these are not sold for human use.
- Any site claiming to sell "prescription AOD 9604" for human use in the U.S. is operating outside the current regulatory framework.
The regulatory picture first, then the price
It's difficult to discuss AOD 9604 cost without first being clear about what the drug actually is and isn't, regulatorily. AOD 9604 is not an FDA-approved drug. It completed Phase IIb clinical trials in 2007 but did not meet the primary endpoint and was never submitted for FDA approval. Since then, it has existed in a gray zone — used in research, compounded by certain pharmacies for a window of years, and sold in research-chemical markets globally.
For a stretch of time, compounding pharmacies in the U.S. could compound AOD 9604 for individual patients under section 503A of the Federal Food, Drug, and Cosmetic Act, which allows licensed compounders to prepare medications not commercially available. The FDA maintains a "bulks list" — formally the 503A Bulk Drug Substances list — that specifies which non-FDA-approved substances can be used in compounding. AOD 9604 was removed from this pathway in subsequent FDA rulings, meaning that as of 2026, compounding pharmacies should not be preparing AOD 9604 for patient use in the U.S.
AOD 9604 cost during the compounding era
During the years when AOD 9604 was compounded in the U.S., cash prices at telehealth peptide clinics and compounding pharmacies generally fell in the following range:
| Format | Typical price range (historical) | Notes |
|---|---|---|
| Subcutaneous 5 mg vial | $80–$150 | One vial lasted ~2 weeks at 300 mcg/day |
| Subcutaneous 10 mg vial | $120–$220 | One vial lasted ~4–5 weeks at 300 mcg/day |
| Monthly subcutaneous protocol | $150–$300 | Depending on compounder and volume |
| Oral troche | $80–$180/month | Lower systemic exposure; cheaper to supply |
| Telehealth clinic program | $200–$400/month | Bundled provider visit + compounded peptide |
These are historical figures from the period when AOD 9604 was still being compounded under 503A. They should not be read as current pricing. With the drug off the FDA bulks list, these programs are no longer operating legally in the U.S.
AOD 9604 price in research chemical markets
AOD 9604 continues to be sold in international research chemical markets — typically as lyophilized powder in 2 mg, 5 mg, or 10 mg vials. Prices on these markets are typically far lower than compounding pharmacy pricing because the product is not labeled for human use and does not pass through the same quality controls.
- 2 mg vial: $15–$40
- 5 mg vial: $30–$70
- 10 mg vial: $60–$120
Research chemical suppliers explicitly label their products "for research purposes only, not for human consumption." These products are not manufactured under FDA current good manufacturing practice (cGMP), are not third-party tested for identity, purity, potency, or endotoxin contamination, and carry real quality and safety risks. The cost advantage over historical compounding pricing comes directly from the absence of these quality controls.
Where to buy AOD 9604 (the honest answer)
As of 2026 there is no legitimate U.S. retail source for AOD 9604. The options that exist fall into three categories, each with significant problems:
- Telehealth clinics claiming to prescribe AOD 9604. With the drug off the 503A bulks list, any U.S.-based clinic offering "prescription AOD 9604" is operating in a murky regulatory zone. Some operate in states with looser enforcement, others import compounded material from jurisdictions with different rules. Due diligence on the actual pharmacy source, lab testing, and clinician licensing is essential.
- International compounding pharmacies. Some countries have different regulatory frameworks that still permit AOD 9604 compounding. Importing prescription medications across borders has its own legal issues and does not automatically mean the material is cGMP-grade.
- Research chemical suppliers. Explicitly not for human use, not tested, not regulated. Inexpensive but risky.
The legitimate path forward
For individuals interested in peptide therapy through a licensed, supervised channel, the cleaner approach is to work with a physician under standard medical care, using peptides that have a clear regulatory pathway and quality-controlled pharmacy sourcing. AOD 9604 is not in that category as of 2026. The peptides currently available through legitimate U.S. compounding pathways are a different and shorter list, and AOD 9604 is not on it.
Regulatory reminder
The purchase, possession, and self-administration of unapproved peptides carries real legal and health risks. Prices quoted on this page are drawn from publicly available historical data and international market reporting; none of this constitutes a recommendation to buy or use AOD 9604 outside of licensed medical supervision.
Frequently asked questions
How much does AOD 9604 cost?
Historical compounding pharmacy prices ran $150–$300/month for subcutaneous protocols. Research chemical market prices are $30–$120 per vial but are not for human use. As of 2026 there is no legitimate U.S. retail source.
Can you get AOD 9604 with a prescription?
Not legitimately in the U.S. as of 2026. AOD 9604 was removed from the FDA 503A bulk drug substances list, which previously allowed compounding pharmacies to prepare it for individual patients. Any U.S.-based provider currently offering 'prescription AOD 9604' is operating outside that framework.
Where can I buy AOD 9604?
The honest answer is that there is no legitimate U.S. retail source. International compounding pharmacies and research chemical suppliers exist but each carries legal and quality risks. There is no current FDA-approved path.
Why is AOD 9604 cheaper on research chemical sites?
Because those products are not manufactured under pharmaceutical quality standards, are not tested for purity or sterility, and are explicitly labeled 'not for human consumption.' The price reflects the absence of those quality controls.
Will AOD 9604 be added back to the compounding list?
Unknown. The FDA's 503A rulings on peptides have been revised several times, and future inclusion or exclusion depends on FDA evaluation and peptide industry advocacy. There is no reliable public timeline.